Randomized Phase 3 Trial of Adjuvant Androgen Deprivation in Combination With High-Dose Conformal Radiation Therapy in Intermediate- and High-Risk Localized Prostate Cancer

2014 ◽  
Vol 90 (1) ◽  
pp. S1 ◽  
Author(s):  
A. Zapatero ◽  
A. Guerrero ◽  
J. Maldonado ◽  
A. Alvarez ◽  
C. Gonzalez San Segundo ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Radiation Therapy ◽  
High Risk ◽  
Androgen Deprivation ◽  
Localized Prostate Cancer ◽  
High Dose ◽  
Phase 3 ◽  
Conformal Radiation Therapy

Randomised phase 3 trial of enzalutamide in androgen deprivation therapy with radiation therapy for high risk, clinically localised prostate cancer: The ANZUP ENZARAD Trial (ANZUP 1303).

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. TPS5078-TPS5078
Author(s):  
Scott G. Williams ◽  
Ian D. Davis ◽  
Christopher Sweeney ◽  
Martin R. Stockler ◽  
Andrew James Martin ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Radiation Therapy ◽  
High Risk ◽  
Androgen Deprivation Therapy ◽  
Androgen Deprivation ◽  
Phase 3

Randomised phase 3 trial of enzalutamide in androgen deprivation therapy (ADT) with radiation therapy for clinically localised high-risk or node-positive prostate cancer: ENZARAD (ANZUP 1303).

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. TPS5086-TPS5086 ◽  
Author(s):  
Scott G. Williams ◽  
Ian D. Davis ◽  
Christopher Sweeney ◽  
Martin R. Stockler ◽  
Andrew James Martin ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Radiation Therapy ◽  
High Risk ◽  
Androgen Deprivation Therapy ◽  
Androgen Deprivation ◽  
Phase 3 ◽  
Node Positive
Sign in / Sign up

Export Citation Format

Share Document